J&J Separates U.S. OTCs In "Unorthodox" Reorg To Get McNeil Back On Track
This article was originally published in The Tan Sheet
Executive Summary
As the new head of Johnson & Johnson's beleaguered U.S. OTC business, Pat Mutchler takes on the burden of restoring the firm's reputation and manufacturing quality.
You may also be interested in...
McCoy Exits J&J For Avon After Gorsky Promotion
Passed over to succeed outgoing CEO William Weldon, top Johnson & Johnson consumer business exec Sheri McCoy exits the firm after 30 years to become Avon’s CEO. While J&J’s consumer business is recovering gradually, Avon faces a hostile takeover bid and is dealing with internal struggles.
McCoy Exits J&J For Avon After Gorsky Promotion
Passed over to succeed outgoing CEO William Weldon, top Johnson & Johnson consumer business exec Sheri McCoy exits the firm after 30 years to become Avon’s CEO. While J&J’s consumer business is recovering gradually, Avon faces a hostile takeover bid and is dealing with internal struggles.
J&J Consumer Leadership Reshuffle Continues
Johnson & Johnson continues reorganizing its consumer teams as the firm deals with several years of quality control problems in its McNeil Consumer Healthcare unit.